EUVIMEDEUVIMED entdecken
Crossref

AdipoRon attenuates steatosis, inflammation and fibrosis in murine diet‐induced NASH via inhibiting ER stress

Lulin Nie, Kaiwu He, Wei Wu, Huan Zhang, Chuanyue Gao, Bocheng Xiong, Shangming Li, Yongmei Xie, Haihui Xie, Xifei Yang iD

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.16542 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Lulin Nie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Tenth Affiliated Hospital of Southern Medical University (Dongguan People's Hospital), Dongguan, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Endoplasmic Reticulum Stress, Piperidines, Inflammation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Sanming Project of Medicine in Shenzhen, Guangdong Provincial Basic and Applied Basic Research Foundation Enterprise Joint Fund, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The rising global prevalence of obesity has accelerated the incidence of metabolic dysfunction‐associated steatotic liver disease (MASLD), with nonalcoholic steatohepatitis (NASH) representing its progressive and life‐threatening phenotype. Despite its clinical urgency, no pharmacotherapy is currently approved for NASH. AdipoRon, an orally active adiponectin receptor agonist, exhibits dual regulatory effects on glucose/lipid homeostasis alongside anti‐inflammatory and antioxidant properties. However, its therapeutic potential in metabolic stress‐driven NASH remains underexplored. This study elucidates the efficacy and molecular mechanisms of AdipoRon in mitigating metabolic stress‐induced NASH. Materials and Methods We employed a multi‐modal approach combining in vitro and in vivo models: palmitic acid (PA)‐challenged alpha mouse liver 12 (AML12) hepatocytes and mice fed a Western diet (WD) or a methionine‐choline‐deficient (MCD) diet. Proteomic profiling integrated with bioinformatics analysis was utilized to dissect AdipoRon's mechanism. Pharmacological validation via endoplasmic reticulum (ER) stress modulation (e.g., cinchonine) further clarified pathway specificity.

Results

In vitro, AdipoRon attenuated PA‐induced lipid accumulation and inflammatory cytokine release in hepatocytes. In vivo, AdipoRon administration markedly reduced hepatic injury, steatosis, lobular inflammation and collagen deposition in diet‐induced NASH mice. Mechanistically, proteomic analysis identified ER stress suppression as a central pathway, with rescue experiments confirming that cinchonine (an ER stress activator) abrogated AdipoRon's hepatoprotection.

Conclusions

Our findings establish AdipoRon as a potent inhibitor of ER stress, effectively counteracting metabolic stress‐induced NASH pathogenesis. These results highlight its translational promise as a targeted therapy for NASH, addressing critical unmet clinical needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseEndoplasmic Reticulum StressPiperidinesInflammationLiver CirrhosisAnimalsMiceMaleDiet, WesternHepatocytesMice, Inbred C57BLLiverDisease Models, AnimalLipid MetabolismReceptors, Adiponectin

Stichwörter der Autor:innen

AdipoRonendoplasmic reticulum (ER) stresslipid accumulationnon‐alcoholic steatohepatitis (NASH)

Substanzen

AdipoRonPiperidinesReceptors, Adiponectin

Autor:innen und Institutionen

  • Department of Anesthesiology, The Tenth Affiliated Hospital of Southern Medical University (Dongguan People's Hospital), Dongguan, China.
  • Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology (2020-2024), Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
  • Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, Guangdong Medical University, Dongguan, China.
  • Department of Hematology, Shenzhen Hospital of Southern Medical University, Shenzhen, China.
  • State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, China.

ORCID-Profile: Xifei Yang

Förderung

  • Sanming Project of Medicine in Shenzhen
  • Guangdong Provincial Basic and Applied Basic Research Foundation Enterprise Joint Fund
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Shenzhen Key Medical Discipline Construction Fund
  • Shenzhen Science and Technology Program
  • Sanming Project of Medicine in Shenzen Municipality

Zitieren

APA

Nie, L., He, K., Wu, W., Zhang, H., Gao, C., Xiong, B., Li, S., Xie, Y., Xie, H., & Yang, X. (2025). AdipoRon attenuates steatosis, inflammation and fibrosis in murine diet‐induced NASH via inhibiting ER stress. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16542

Vancouver

Nie L, He K, Wu W, Zhang H, Gao C, Xiong B, et al. AdipoRon attenuates steatosis, inflammation and fibrosis in murine diet‐induced NASH via inhibiting ER stress. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16542

BibTeX
@article{Nie2025,
  author = {Nie, Lulin and He, Kaiwu and Wu, Wei and Zhang, Huan and Gao, Chuanyue and Xiong, Bocheng and Li, Shangming and Xie, Yongmei and Xie, Haihui and Yang, Xifei},
  title = {AdipoRon attenuates steatosis, inflammation and fibrosis in murine diet‐induced NASH via inhibiting ER stress},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.16542}
}
Kostenlos starten →